Study Summary:
This is an 8 week study to evaluate the efficacy, safety, and tolerability of an investigational medication in combination with an approved medication in patients with major depressive disorder.
Qualified Participants Must:
• Male or female
•
Be 18-65 years old
•
Diagnosis of major depressive disorder
Qualified Participants May Receive:
Compensation for time and travel